Failure of high-dose vitamin E to correct ceruloplasmin ferroxidase deficiency in cigarette smokers

E. R. Pacht, W. B. Davis

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Cigarette smokers have a biochemical defect in the ferroxidase activity of their serum ceruloplasmin. Ceruloplasmin is one of the main serum antioxidants, and this defect in ferroxidase activity most likely accounts for the previously observed decrease in smoker serum antioxidant activity. This defect may be related to oxidation of ceruloplasmin in the lung. We hypothesized that vitamin E might be able to reverse the decrease in smoker ferroxidase activity and thus restore serum antioxidant activity. To test this hypothesis, we administered high-dose vitamin E to a group of young asymptomatic cigarette smokers (n = 8). Although serum levels of vitamin E significantly increased (8.7 ± 0.8 to 20.6 ± 3.1 μg/ml, p = 0.01), the ferroxidase activity of smoker serum (0.139 ± 0.02 to 0.144 ± 0.03 U/ml, p = 0.824), and the antioxidant activity of serum (45.8 ± 7.2 to 51.6 ± 8.4%, p = 0.587) remained unchanged. Thus, at the current dose and duration of supplementation, vitamin E was unable to reverse the defect in smoker serum ferroxidase activity and thus unable to augment the antioxidant capacity of the serum.

Original languageEnglish (US)
Pages (from-to)1063-1067
Number of pages5
JournalAmerican Review of Respiratory Disease
Volume142
Issue number5
DOIs
StatePublished - Jan 1 1990

Fingerprint

Ceruloplasmin
Vitamin E
Tobacco Products
Serum
Antioxidants
Familial apoceruloplasmin deficiency
Lung

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine

Cite this

Failure of high-dose vitamin E to correct ceruloplasmin ferroxidase deficiency in cigarette smokers. / Pacht, E. R.; Davis, W. B.

In: American Review of Respiratory Disease, Vol. 142, No. 5, 01.01.1990, p. 1063-1067.

Research output: Contribution to journalArticle

@article{7b943938d854477e895a98273b86026b,
title = "Failure of high-dose vitamin E to correct ceruloplasmin ferroxidase deficiency in cigarette smokers",
abstract = "Cigarette smokers have a biochemical defect in the ferroxidase activity of their serum ceruloplasmin. Ceruloplasmin is one of the main serum antioxidants, and this defect in ferroxidase activity most likely accounts for the previously observed decrease in smoker serum antioxidant activity. This defect may be related to oxidation of ceruloplasmin in the lung. We hypothesized that vitamin E might be able to reverse the decrease in smoker ferroxidase activity and thus restore serum antioxidant activity. To test this hypothesis, we administered high-dose vitamin E to a group of young asymptomatic cigarette smokers (n = 8). Although serum levels of vitamin E significantly increased (8.7 ± 0.8 to 20.6 ± 3.1 μg/ml, p = 0.01), the ferroxidase activity of smoker serum (0.139 ± 0.02 to 0.144 ± 0.03 U/ml, p = 0.824), and the antioxidant activity of serum (45.8 ± 7.2 to 51.6 ± 8.4{\%}, p = 0.587) remained unchanged. Thus, at the current dose and duration of supplementation, vitamin E was unable to reverse the defect in smoker serum ferroxidase activity and thus unable to augment the antioxidant capacity of the serum.",
author = "Pacht, {E. R.} and Davis, {W. B.}",
year = "1990",
month = "1",
day = "1",
doi = "10.1164/ajrccm/142.5.1063",
language = "English (US)",
volume = "142",
pages = "1063--1067",
journal = "American Journal of Respiratory and Critical Care Medicine",
issn = "1073-449X",
publisher = "American Thoracic Society",
number = "5",

}

TY - JOUR

T1 - Failure of high-dose vitamin E to correct ceruloplasmin ferroxidase deficiency in cigarette smokers

AU - Pacht, E. R.

AU - Davis, W. B.

PY - 1990/1/1

Y1 - 1990/1/1

N2 - Cigarette smokers have a biochemical defect in the ferroxidase activity of their serum ceruloplasmin. Ceruloplasmin is one of the main serum antioxidants, and this defect in ferroxidase activity most likely accounts for the previously observed decrease in smoker serum antioxidant activity. This defect may be related to oxidation of ceruloplasmin in the lung. We hypothesized that vitamin E might be able to reverse the decrease in smoker ferroxidase activity and thus restore serum antioxidant activity. To test this hypothesis, we administered high-dose vitamin E to a group of young asymptomatic cigarette smokers (n = 8). Although serum levels of vitamin E significantly increased (8.7 ± 0.8 to 20.6 ± 3.1 μg/ml, p = 0.01), the ferroxidase activity of smoker serum (0.139 ± 0.02 to 0.144 ± 0.03 U/ml, p = 0.824), and the antioxidant activity of serum (45.8 ± 7.2 to 51.6 ± 8.4%, p = 0.587) remained unchanged. Thus, at the current dose and duration of supplementation, vitamin E was unable to reverse the defect in smoker serum ferroxidase activity and thus unable to augment the antioxidant capacity of the serum.

AB - Cigarette smokers have a biochemical defect in the ferroxidase activity of their serum ceruloplasmin. Ceruloplasmin is one of the main serum antioxidants, and this defect in ferroxidase activity most likely accounts for the previously observed decrease in smoker serum antioxidant activity. This defect may be related to oxidation of ceruloplasmin in the lung. We hypothesized that vitamin E might be able to reverse the decrease in smoker ferroxidase activity and thus restore serum antioxidant activity. To test this hypothesis, we administered high-dose vitamin E to a group of young asymptomatic cigarette smokers (n = 8). Although serum levels of vitamin E significantly increased (8.7 ± 0.8 to 20.6 ± 3.1 μg/ml, p = 0.01), the ferroxidase activity of smoker serum (0.139 ± 0.02 to 0.144 ± 0.03 U/ml, p = 0.824), and the antioxidant activity of serum (45.8 ± 7.2 to 51.6 ± 8.4%, p = 0.587) remained unchanged. Thus, at the current dose and duration of supplementation, vitamin E was unable to reverse the defect in smoker serum ferroxidase activity and thus unable to augment the antioxidant capacity of the serum.

UR - http://www.scopus.com/inward/record.url?scp=0025083337&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025083337&partnerID=8YFLogxK

U2 - 10.1164/ajrccm/142.5.1063

DO - 10.1164/ajrccm/142.5.1063

M3 - Article

VL - 142

SP - 1063

EP - 1067

JO - American Journal of Respiratory and Critical Care Medicine

JF - American Journal of Respiratory and Critical Care Medicine

SN - 1073-449X

IS - 5

ER -